Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.

Kaur, Maneet; Frahm, Filip; Lu, Yichen; Ascha, Mustafa S; Guadamuz, Jenny S; Dotan, Efrat; Gottesman, Adam S; Leybovich, Barry C; Sondhi, Arjun; Zhao, Yihua; Meropol, Neal J; Royce, Trevor J

Kaur, Maneet; Frahm, Filip; Lu, Yichen; Ascha, Mustafa S; Guadamuz, Jenny S; Dotan, Efrat; Gottesman, Adam S; Leybovich, Barry C; Sondhi, Arjun; Zhao, Yihua; Meropol, Neal J; Royce, Trevor J.

Affiliation

Kaur M; Flatiron Health, New York.
Frahm F; Flatiron Health, New York.
Lu Y; Flatiron Health, New York.
Ascha MS; Flatiron Health, New York.
Guadamuz JS; Flatiron Health, New York.
Dotan E; School of Public Health, Division of Health Policy and Management, University of California, Berkeley, Berkeley.
Gottesman AS; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia.
Leybovich BC; Flatiron Health, New York.
Sondhi A; Flatiron Health, New York.
Zhao Y; Flatiron Health, New York.
Meropol NJ; Flatiron Health, New York.
Royce TJ; Flatiron Health, New York.

NEJM Evid ; 3(4): EVIDoa2300236, 2024 Apr.

Article in En | MEDLINE | ID: mdl-38771994

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Patient Selection / Eligibility Determination / Neoplasms Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: NEJM Evid Year: 2024 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google